108
|
316
|
5ha7A |
Human aldose reductase in complex with nadp+ and wy14643 in space group p212121 |
118
|
315
|
5hnuA |
Crystal structure of akr1c3 complexed with octyl gallate |
118
|
345
|
5az0A |
Crystal structure of aldo-keto reductase (akr2e5) of the silkworm, bombyx mori |
119
|
345
|
5az1A |
Crystal structure of aldo-keto reductase (akr2e5) complexed with nadph |
116
|
315
|
4yvxA |
Crystal structure of akr1c3 complexed with glimepiride |
107
|
274
|
5danA |
Crystal structure of a novel aldo keto reductase tm1743 from thermotoga maritima in complex with nadp+ |
116
|
315
|
4yvvA |
Crystal structure of akr1c3 complexed with glibenclamide |
115
|
318
|
4yvpA |
Crystal structure of akr1c1 complexed with glibenclamide |
109
|
316
|
4yu1A |
Human aldose reductase complexed with schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at 1.02 a |
116
|
325
|
4xo6A |
Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with nadp+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one |
114
|
316
|
4xzhA |
Crystal structure of human aldose reductase complexed with nadp+ and jf0048 |
90
|
316
|
4xznX |
Crystal structure of the methylated k125r/v301l akr1b10 holoenzyme |
119
|
322
|
4xo7A |
Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with nadp+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one |
117
|
315
|
4xveA |
17beta-hsd5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)quinazolin-4(3h)-one |
107
|
281
|
4xapA |
Crystal structure of aldo-keto reductase from sinorhizobium meliloti 1021 |
104
|
316
|
4xziA |
Crystal structure of human aldose reductase complexed with nadp+ and jf0049 |
116
|
316
|
4xvdA |
17beta-hsd5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol |
93
|
316
|
4xzlX |
Crystal structure of human akr1b10 complexed with nadp+ and jf0049 |
118
|
344
|
4xk2A |
Crystal structure of aldo-keto reductase from polaromonas sp. js666 |
89
|
316
|
4xzmX |
Crystal structure of the methylated wild-type akr1b10 holoenzyme |
119
|
315
|
4wdtA |
17beta-hsd5 in complex with 2-nitro-5-(phenylsulfonyl)phenol |
109
|
306
|
4wdxA |
17beta-hsd5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1h-indol-2-yl)methanone |
116
|
316
|
4wrhA |
Akr1c3 complexed with breakdown product of n-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4h-1,2,4-triazol-4-yl)amino)methyl)-6-methoxyphenoxy)acetamide |
110
|
301
|
4wdwA |
17beta-hsd5 in complex with 3,6-dihydropyridin-1(2h)-yl(5-methyl-1h-indol-2-yl)methanone |
91
|
316
|
4wevX |
Crystal structure of human akr1b10 complexed with nadp+ and sulindac |
118
|
315
|
4wduA |
17beta-hsd5 in complex with 4-chloro-n-(4-chlorobenzyl)-5-nitro-1h-pyrazole-3-carboxamide |
109
|
316
|
4qx4A |
Human aldose reductase complexed with a ligand with a new scaffold at 1.26 a |
107
|
316
|
4qr6A |
Human aldose reductase complexed with a ligand with an idd structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 a |
108
|
314
|
4qxiA |
Crystal structure of human ar complexed with nadp+ and ak198 |
108
|
314
|
4rpqA |
Human aldose reductase complexed with a ligand with an idd structure at 1.20 a (1) |
108
|
316
|
4qbxA |
Human aldose reductase complexed with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 a |
99
|
293
|
4r9oA |
Crystal structure of putative aldo/keto reductase from salmonella enterica |
107
|
316
|
4puwA |
Human aldose reductase complexed with a ligand with an idd structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 a |
112
|
315
|
4prrA |
Human aldose reductase complexed with schl7815 ((3-[3-(5-nitrofuran-2-yl)phenyl]propanoic acid)at 1.01 a |
107
|
316
|
4puuA |
Human aldose reductase complexed with a ligand with an idd structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 a |
109
|
315
|
4pr4A |
Human aldose reductase complexed with schl7802 at 1.06 a |
111
|
316
|
4prtA |
Human aldose reductase complexed with schl12221 ({2-[5-(3-nitrophenyl)furan-2-yl]phenyl}acetic acid) at 0.96 a |
102
|
281
|
4pmjA |
Crystal structure of a putative oxidoreductase from sinorhizobium meliloti 1021 in complex with nadp |
108
|
315
|
4q7bA |
Human aldose reductase complexed with a ligand with an idd structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 a |
105
|
276
|
4otkA |
A structural characterization of the isoniazid mycobacterium tuberculosis drug target, rv2971, in its unliganded form |
101
|
273
|
4q3mA |
Crystal structure of mgs-m4, an aldo-keto reductase enzyme from a medee basin deep-sea metagenome library |
106
|
314
|
4nkcA |
Human aldose reductase complexed with schl7764 at 1.12 a |
103
|
283
|
4mhbA |
Structure of a putative reductase from yersinia pestis |
109
|
316
|
4lb4A |
Crystal structure of human ar complexed with nadp+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid |
111
|
316
|
4lauA |
Crystal structure of human ar complexed with nadp+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid |
110
|
316
|
4lbrA |
Crystal structure of human ar complexed with nadp+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid |
109
|
316
|
4lbsA |
Crystal structure of human ar complexed with nadp+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid |
111
|
316
|
4lazA |
Crystal structure of human ar complexed with nadp+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy}acetic acid |
119
|
325
|
4l1wA |
Crystal structuer of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with nadp+ and progesterone |
119
|
325
|
4l1xA |
Crystal structuer of human 3-alpha hydroxysteroid dehydrogenase type 3 v54l mutant in complex with nadp+ and progesterone |